Skip to main content

With biotech stocks soaring, Atlas Venture raises $400M for new fund

There was well over $1 billion of demand for Atlas Venture's latest fund, according to Partner Kevin Bitterman.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.